SMTL ID : 7r7k.1

Structure of Human Anaplastic Lymphoma Kinase Domain in complex with (4-[6-amino-5-[(1~{R})-1-[5-fluoro-2-(triazol-2-yl)phenyl]ethoxy]-3-pyridyl]isoindolin-1-one)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.83 Å
Oligo State
monomer
Ligands
1 x 25J: 4-(6-amino-5-{(1R)-1-[5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]ethoxy}pyridin-3-yl)-2,3-dihydro-1H-isoindol-1-one(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Shiba-Ishii, A. et al., Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer. Nat Cancer (2022)
Release Date
2022-06-29
Peptides
ALK tyrosine kinase receptor: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

ALK tyrosine kinase receptor

Related Entries With Identical Sequence

2xp2.1 | 4ccb.1 | 4ccu.1 | 4cli.1 | 4cmo.1 | 4cmt.1 | 4cmu.1 | 4cnh.1 | 4cnh.2 | 4ctb.1 | 4ctc.1 | 5imx.1 | 5kz0.1 | 6cdt.1 | 7r7r.1